Michal Preminger, PhD, MBAExecutive Director / Director of Business Development, Harvard Medical School
Michal joined OTD in 2005. Prior to joining Harvard, she held a number of business development and technology development positions at Compugen, most recently as Vice President of Protein Therapeutics, responsible for the business management of the company's emerging drug discovery pipeline. Previously, Michal held several marketing and business development positions in the hi-tech industry, among others for Lucent Technologies. Michal also co-founded a startup company and has been serving on the boards of several not-for-profits, biotech, and medical device companies. Michal holds an undergraduate degree in Medicine from the Hebrew University School of Medicine, a PhD from the Weizmann Institute of Science, and an MBA from INSEAD in Fontainebleau, France.